[1]余 云,沈 红.支气管肺部感染患者经痰标本细菌培养的情况分析[J].医学信息,2023,36(19):137-140.[doi:10.3969/j.issn.1006-1959.2023.19.030]
　YU Yun,SHEN Hong.Analysis of Bacterial Culture of Sputum Specimens in Patients with Bronchopulmonary Infections[J].Journal of Medical Information,2023,36(19):137-140.[doi:10.3969/j.issn.1006-1959.2023.19.030]
点击复制

支气管肺部感染患者经痰标本细菌培养的情况分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年19期
页码:
137-140
栏目:
论著
出版日期:
2023-10-01

文章信息/Info

Title:
Analysis of Bacterial Culture of Sputum Specimens in Patients with Bronchopulmonary Infections
文章编号:
1006-1959（2023）19-0137-04
作者:
余 云; 沈 红
（湖口县中医医院检验科，江西 湖口 332500）
Author(s):
YU Yun; SHEN Hong
(Department of Laboratory,Hukou County Hospital of Traditional Chinese Medicine,Hukou 332500,Jiangxi,China)
关键词:
支气管肺部感染; 痰标本; 细菌培养
Keywords:
Bronchopulmonary infection; Sputum specimen; Bacterial culture
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2023.19.030
文献标志码:
A
摘要:
目的 研究支气管肺部感染患者经痰标本细菌培养的检测价值。方法 选取2019年1月-2022年1月我院诊治的56例支气管肺部感染患者为研究对象，均进行痰标本细菌培养，观察总结痰标本细菌分布情况、不同病情患者细菌分布情况、主要革兰阴性和阳性菌耐药性以及抗菌药物应用不良反应发生情况。结果 56例患者共分离病原菌56株，其中革兰氏阳性10例、革兰氏阴性菌49例，且革兰氏阴性菌排名前4位的分别是肺炎克雷伯菌、铜绿假单胞菌、不动杆菌及大肠埃希菌；重症患者肺炎克雷伯菌检出率高于非重症患者（P＜0.05），铜绿假单胞菌、大肠埃希菌检出率低于非重症患者（P＜0.05），而不动杆菌、其他病原菌检出率与非重症患者比较，差异无统计学意义（P＞0.05）；主要革兰氏阴性菌株对利福平、四环素、万古霉素、替加环素、莫西沙星、阿米卡星、米诺环素、亚胺培南耐药性较弱，克林霉素、红霉素、青霉素、克拉霉素、阿奇霉素、头孢西丁、左氧氟沙星耐药性较强；依据细菌培养结果和耐药性选择合理抗菌药物，临床治疗合理用药率高达96.43%。结论 支气管肺部感染患者进行痰标本细菌培养可明确主要病原菌，并针对耐药性结果选择合理抗菌药物治疗，促进临床疗效的同时，提高治疗安全性。
Abstract:
Objective To study the detection value of bacterial culture of sputum specimens in patients with bronchial pulmonary infection.Methods From January 2019 to January 2022, 56 patients with bronchopulmonary infection diagnosed and treated in our hospital were selected as the research objects. All of them were cultured with sputum specimens. The bacterial distribution of sputum specimens, the bacterial distribution of patients with different conditions, the drug resistance of main Gram-negative and positive bacteria and the occurrence of adverse reactions of antibacterial drugs were observed and summarized.Results A total of 56 strains of pathogenic bacteria were isolated from 56 patients, including 10 strains of Gram-positive bacteria and 49 strains of Gram-negative bacteria. The top four Gram-negative bacteria were Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter and Escherichia coli. The detection rate of Klebsiella pneumoniae in severe patients was higher than that in non-severe patients (P<0.05), and the detection rates of Pseudomonas aeruginosa and Escherichia coli were lower than those in non-severe patients (P<0.05) while the detection rates of Acinetobacter and other pathogens were not significantly different from those in non-severe patients (P>0.05). The main Gram-negative strains had weak resistance to rifampicin, tetracycline, vancomycin, tigecycline, moxifloxacin, amikacin, minocycline and imipenem, and strong resistance to clindamycin, erythromycin, penicillin, clarithromycin, azithromycin, cefoxitin and levofloxacin. According to the results of bacterial culture and drug resistance, reasonable antibacterial drugs were selected, and the rational drug use rate in clinical treatment was as high as 96.43%.Conclusion Bacterial culture of sputum specimens in patients with bronchopulmonary infection can identify the main pathogens, and select reasonable antimicrobial therapy according to the results of drug resistance, so as to promote clinical efficacy and improve the safety of treatment.

参考文献/References:

[1]曹明嫄,吴允萍,宋晓霞,等.注射用重组人脑利钠肽治疗肺源性心脏病急性加重期患者的临床研究[J].中国临床药理学杂志,2021,37(13):1634-1637.[2]蓝运竞,陈兴玲,葛利珍,等.热休克蛋白27和N末端脑利钠肽前体水平与慢性肺源性心脏病分级及预后的关系[J].中国现代医学杂志,2021,31(17):85-90.[3]中华医学会呼吸病学分会感染学组.中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J].中华结核和呼吸杂志,2018,41(4):255-280[4]谢朝云,李耀福,蒙桂鸾,等.老年慢性肺源性心脏病合并肺部多重耐药菌感染相关因素分析[J].解放军医药杂志,2020,32(1):56-59.[5]李燕飞.慢性肺源性心脏病急性加重期患者下呼吸道真菌感染110例临床诊治分析[J].实用临床医药杂志,2017,20(19):154-156.[6]倪荣萍,杨锐,王贵勤.慢性阻塞性肺疾病合并肺部感染患者致病菌特征及对免疫功能的影响[J].武警后勤学院学报(医学版),2020,29(8):46-49.[7]杨迅,王智彬,任志杰,等.肺源性心脏病患者呼吸道感染病原菌分布及耐药性分析[J].中华医院感染学杂志,2017,27(10):2210-2213.[8]韩志梅.痰液标本细菌培养及药敏试验对下呼吸道感染用药的指导作用[J].中国老年保健医学,2021,19(1):129-131.[9]郭红霞.52例复治肺结核并发重症肺炎患者痰液标本细菌培养及药敏试验结果分析[J].实用中西医结合临床,2020,20(12):114-116[10]胡良英,苏美霞,蒋景华,等.慢性肺源性心脏病老年患者呼吸道感染病原菌和耐药分析[J].中华医院感染学杂志,2018,28(11):1650-1653.[11]韩莉,赵真真.87例肺结核合并肺部感染患者痰液标本细菌培养及药敏试验结果分析[J].内蒙古医学杂志,2020,52(9):1042-1043.[12]赵丽萍．喜炎平注射液联合头孢孟多对小儿支气管肺炎的临床疗效评价[J].中国药物与临床,2019,19(8):1348-1349．[13]王艳,吴秋红.鲁南地区小儿支气管肺炎常见病原菌分布及耐药性监测分析[J].中国实用医刊,2019,46(20):20-22．[14]徐英.肺部感染对慢阻肺急性加重期患者外周血淋巴细胞免疫分型的影响[J].临床肺科杂志,2018,23(8):1450-1454.[15]程国栋,王海玲,王玉清．肺结核患者合并肺部感染病原菌的种类、血清蛋白水平及分枝杆菌耐药性分析[J].中国病原生物学杂志,2020,15(2):217-220．[16]杨强,郭曌晋.痰标本细菌培养及药敏试验对多发性骨髓瘤肺部感染患者抗菌药物合理应用的影响[J].基层医学论坛,2020,24(26):3781-3783.[17]侯晶晶.痰液标本细菌培养及药敏试验对肺癌患者姑息疗法后肺部感染抗菌药物合理使用的影响[J].抗感染药学,2019,16(11):1877-1880.

更新日期/Last Update: 1900-01-01